Adaptilens

adaptilens.com

Adaptilens is a pioneering company focused on developing the first biomimetic accommodating intraocular lens (A-IOL) that mimics the natural lens of a young, healthy eye. Their innovative technology aims to revolutionize cataract surgery by providing a soft, flexible lens that restores a full range of vision without the need for glasses, addressing the limitations of traditional rigid lenses. With a significant market opportunity, given that over 30 million cataract surgeries are performed globally each year, Adaptilens is positioned to capture a substantial share of this growing market. The company has recently secured $17.5 million in Series A financing, indicating strong investor confidence and traction in the ophthalmic device sector.